Radioligand Therapies (RLT) Associate Director, Priority Accounts – Kentucky/Tennessee/South Carolina

Summary This is a field-based and remote opportunity supporting key accounts in an assigned geography. Novartis is unable to offer relocation support for this role. Please only apply if this location is accessible to you. Company will not sponsor visas for this position. As a Radioligand Therapies (RLT) Associate Director, Priority Accounts, you’ll partner with Neuroendocrine Tumors (NET) Centers of Excellence and health care system sites to drive impactful engagement. This role focuses on creating and executing strategic business plans for key accounts while collaborating with cross-functional teams to deliver institution-centric programs aligned with business priorities and compliance standards. You’ll lead commercial strategies, foster strong relationships with senior stakeholders, and provide operational and financial insights to uncover new opportunities. Success in this position calls for expertise in healthcare systems, access navigation, and collaborative problem-solving. About The Role Key Responsibilities: Champion institutional advocacy for the adoption of the Radioligand Therapies (RLT) and Neuroendocrine Tumors (NET) brand to support appropriate product utilization.Build strong partnerships with Neuroendocrine Tumors Centers of Excellence and health care system sites to drive impactful engagement.Develop, coordinate, and execute strategic business plans for priority accounts, ensuring alignment with market dynamics and organizational goals.Cultivate relationships with clinical, operational, and administrative decision-makers; and support their efforts to streamline care pathways, treatment protocols and workflow solutions to enable patient access.Stay informed on market trends, customer economics, and access models, including payment programs and reimbursement strategies.Compliantly share knowledge of Novartis’ offerings and ensure account administrators have access to relevant resources, while maintaining compliance.Collaborate with local teams to create tailored, institution-specific plans that reflect local market forces and opportunities.Educate clinicians, staff and other institutional stakeholders on disease state and/or product information as appropriate to support institutional adoption of Radioligand Therapies (RLT) and development of relevant treatment pathways and protocols.Develop a clear understanding of customer needs across the ecosystem – from departments to executive leadership. Use insights to anticipate trends, shape priorities, and deliver impactful outcomes.Support team members in diagnosing business challenges and implementing strategies that optimize outcomes for Radioligand Therapies and Neuroendocrine Tumors accounts and affiliated health systems. Essential Requirements Bachelor’s degree required from 4-year college or university. 8+ years’ experience in pharmaceutical, biotech, healthcare, or similarly structured industries with large, geographically dispersed field teams. We also welcome candidates from other complex environments such as medical devices, diagnostics, life sciences services, insurance, consumer health, or B2B sectors, especially where strong field leadership and customer engagement are central to success. 2+ years’ experience in project management and translation of strategy into execution.3+ years’ experience managing complex accounts, including large academic centers and hospitals, with demonstrated success in strategic account management.Recent US experience (within last 5 years) with deep understanding of US healthcare ecosystems.Demonstrated deep customer and cross-functional knowledge, healthcare ecosystem thinking, with strong business acumen and technology/digital engagement proficiency.Robust business background, with strong ability to collaborate and work cross-functionally in a matrix environment to build effective strategic account plans aligned to customer and organization goals.Candidate must reside within territory or reside in a territory adjacent to the a